首页> 外文OA文献 >Live-cell imaging of drug delivery by mesoporous silica nanoparticles
【2h】

Live-cell imaging of drug delivery by mesoporous silica nanoparticles

机译:通过介孔二氧化硅纳米粒子进行药物递送的活细胞成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In order to deliver drugs to diseased cells nanoparticles featuring controlled drug release are developed.Controlled release is of particular importance for the delivery of toxic anti-cancer drugs that should not get in contact with healthy tissue. To evaluate the effectivity and controlled drug release ability of nanoparticles in the target cell, live-cell imaging by highly-sensitive fluorescence microscopy is a powerful method. It allows direct real-time observation of nanoparticle uptake intothe target cell, intracellular trafficking and drug release. With this knowledge, existing nanoparticlescan be evaluated, improved and more effective nanoparticles can be designed. The goal of this work was to study the internalization efficiency, successful drug loading, pore sealing and controlled drug release from colloidal mesoporous silica (CMS) nanoparticles. The entire work was performed in close collaboration with the group of Prof. Thomas Bein (LMU Munich), where the nanoparticleswere synthesized.To deliver drugs into a cell, the extracellular membrane has to be crossed. Therefore, in the first part of this work, the internalization efficiency of PEG-shielded CMS nanoparticles into living HeLa cells was examined by a quenching assay. The internalization time scales varied considerably from cell to cell. However, about 67% of PEG-shielded CMS nanoparticles were internalized by the cells within one hour. The time scale is found to be in the range of other nanoparticles (polyplexes,magnetic lipoplexes) that exhibit non-specific uptake.Besides internalization efficiency, successful drug loading and pore sealing are important parameters for drug delivery. To study this, CMS nanoparticles were loaded with the anti-cancer drug colchicine and sealed by a supported lipid bilayer using a solvent exchange method (additional collaboration with the group of Prof. Joachim Rädler, LMU). Spinning disk confocal live-cell imaging revealed that the nanoparticles were taken up into HuH7 cells by endocytosis. As colchicine is known to exhibit toxicity towards microtubules, the microtubule network of the cells was destroyed within 2 h of incubation with the colchicine-loaded lipid bilayer-coated CMS nanoparticles. Although successful drug delivery was shown, it is necessary to develop controlled local release strategies.To achieve controlled drug release, CMS nanoparticles for redox-driven disulfide cleavage were synthesized.The particles contain the ATTO633-labeled amino acid cysteine bound via a disulfide linker to the inner volume. For reduction of the disulfide bond and release of cysteine, the CMS nanoparticles need to get into contact with the cytoplasmic reducing milieu of the target cell. Weshowed that nanoparticles were taken up by HuH7 cells via endocytosis, but endosomal escape seems to be a bottleneck for this approach. Incubation of the cells with a photosensitizer (TPPS2a) and photoactivation led to endosomal escape and successful release of the drug. In addition, we showed that linkage of ATTO633 at high concentration in the pores of silica nanoparticles results in quenching of the ATTO633 fluorescence. Release of dye from the pores promotes a strong dequenching effect providing an intense fluorescence signal with excellent signal-to-noise ratio for single-particle imaging. With this approach, we were able to control the time of photoactivation and thus the time of endosomal rupture. However, the photosensitizer showed a high toxicity to the cell, due to its presence in the entire cellular membrane.To reduce cell toxicity induced by the photosensitizer and to achieve spatial control on the endosomal escape, the photosensitizer protoporphyrin IX (PpIX) was covalently surface-linked to the CMS nanoparticles and used as an on-board photosensitizer (additional collaboration with the groups of Prof. Joachim Rädler and Prof. Heinrich Leonhardt, both LMU). The nanoparticles were loadedwith model drugs and equipped with a supported lipid bilayer as a removable encapsulation. Upon photoactivation, successful drug delivery was observed. The mode of action is proposed as a two step cascade, where the supported lipid bilayer is disintegrated by singlet oxygen in a first step and the endosomal membrane ruptures enabling drug release in a second step. With this system, stimuli-responsive and controlled, localized endosomal escape and drug release is achieved.Taken together, the data presented in this thesis show that real-time fluorescence imaging of CMS nanoparticles on a single-cell level is a powerful method to investigate in great detail the processes associated with drug delivery. Barriers in the internalization and drug delivery are detected and can be bypassed via new nanoparticle designs. These insights are of great importance for improvements in the design of existing and the synthesis of new drug delivery systems.
机译:为了将药物递送至患病细胞,开发了具有受控药物释放特性的纳米颗粒。对于释放不应与健康组织接触的有毒抗癌药物,控制释放尤为重要。为了评估纳米粒子在靶细胞中的有效性和药物控制释放能力,通过高灵敏度荧光显微镜对活细胞成像是一种有效的方法。它可以直接实时观察纳米颗粒摄入靶细胞,细胞内运输和药物释放。有了这些知识,就可以评估,改进和设计更有效的现有纳米粒子。这项工作的目的是研究胶体介孔二氧化硅(CMS)纳米粒子的内在化效率,成功的载药量,孔密封和受控的药物释放。整个工作是与Thomas Bein教授(LMU慕尼黑)紧密合作完成的,纳米颗粒是在纳米管中合成的。为了将药物输送到细胞中,必须穿过细胞外膜。因此,在这项工作的第一部分中,通过猝灭测定法检测了PEG保护的CMS纳米粒子在活HeLa细胞中的内在化效率。内部化时间尺度在每个单元之间有很大差异。然而,约67%的PEG屏蔽的CMS纳米颗粒在1小时内被细胞内化。发现时间范围在表现出非特异性吸收的其他纳米颗粒(多链体,磁性脂复合体)的范围内。除了内在化效率之外,成功的载药量和孔密封是药物递送的重要参数。为了对此进行研究,CMS纳米颗粒装载了抗癌药物秋水仙碱,并使用溶剂交换方法(与LMU的JoachimRädler教授小组合作)用支持的脂质双层密封。旋转盘共聚焦活细胞成像显示,纳米颗粒通过内吞作用吸收到HuH7细胞中。由于已知秋水仙碱对微管具有毒性,因此在与负载秋水仙素的脂质双层包被的CMS纳米颗粒孵育2小时后,细胞的微管网络被破坏。尽管显示出成功的药物递送,但是有必要制定控制局部释放的策略。为了实现控制的药物释放,合成了用于氧化还原驱动的二硫键裂解的CMS纳米颗粒,该颗粒包含通过二硫键与ATTO633标记的氨基酸半胱氨酸结合。内部体积。为了减少二硫键和释放半胱氨酸,CMS纳米颗粒需要与靶细胞的胞质还原环境接触。我们表明,纳米粒被内吞作用通过HuH7细胞吸收,但内体逃逸似乎是该方法的瓶颈。用光敏剂(TPPS2a)孵育细胞并进行光激活可导致内体逃逸并成功释放药物。另外,我们显示出在二氧化硅纳米颗粒的孔中高浓度的ATTO633的键合导致ATTO633荧光的猝灭。染料从孔中的释放促进了强大的去猝灭效果,从而为单颗粒成像提供了具有出色信噪比的强荧光信号。通过这种方法,我们能够控制光激活的时间,从而控制内体破裂的时间。然而,由于光敏剂存在于整个细胞膜中,因此对细胞具有高毒性。为了降低光敏剂诱导的细胞毒性并实现对内体逃逸的空间控制,光敏剂原卟啉IX(PpIX)共价表面-与CMS纳米粒子连接,并用作机载光敏剂(与LMU的JoachimRädler教授和Heinrich Leonhardt教授小组进行了进一步合作)。纳米颗粒装载有模型药物,并配备有支持的脂质双层作为可去除的胶囊。光活化后,观察到成功的药物递送。提议的作用方式为两步级联反应,其中第一步通过单线态氧使负载的脂质双层分解,第二步通过内体膜破裂使药物释放。综上所述,本论文提供的数据表明,在单细胞水平上对CMS纳米粒子进行实时荧光成像是一种有力的研究方法。详细介绍了与药物输送相关的过程。可以检测到内在化和药物输送中的障碍,可以通过新的纳米颗粒设计绕过障碍。这些见解对于改进现有设计和新药物输送系统的合成至关重要。

著录项

  • 作者

    Sauer Anna Magdalena;

  • 作者单位
  • 年度 2011
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号